An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Evoqua Water Technologies Announces Proposed Settlement of Stockholder Derivative Action
Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary
Evoqua Water Technologies Corp. (NYSE: AQUA) announced a preliminary court approval for a settlement regarding the stockholder derivative action filed in the United States District Court for the Western District of Pennsylvania. The court's order was issued on August 23, 2021, with a hearing set for November 2, 2021, for final approval. The settlement will see enhanced corporate governance measures, including appointing an independent director, improved risk management protocols, and ethics training for employees.
Positive
Implementation of enhanced corporate governance measures.
Appointment of an independent director to the Board.
Establishment of a management-level Risk Committee.
Negative
None.
PITTSBURGH--(BUSINESS WIRE)--
Evoqua Water Technologies Corp. (NYSE: AQUA), a leader in mission-critical water treatment solutions, today announced that on August 23, 2021, the United States District Court for the Western District of Pennsylvania entered an order preliminarily approving a settlement of the previously disclosed stockholder derivative action entitled In re Evoqua Water Technologies Corp. Derivative Litigation and scheduling a hearing for November 2, 2021, to determine whether to give final approval to the settlement.
Under the settlement agreement, the company agreed to implement a series of enhanced corporate governance measures, including the replacement of a non-independent director serving on the company’s Board of Directors with a new director who meets the New York Stock Exchange criteria for director independence; enhancements to the responsibilities and duties of the company’s Director of Ethics and Compliance position; additions to the charter of the Compensation Committee of the Board of Directors; employee training in risk assessment and compliance; mandatory continuing director education programs; and the establishment of a management-level Risk Committee responsible for the company’s risk management policies and oversight of the operations of the company’s risk management framework.
A copy of the court-approved notice of the proposed settlement describing the litigation and the settlement in greater detail and specifying the procedures and deadlines for any stockholder objections is available, along with a copy of the full stipulation of settlement, on Evoqua’s Investor Relations website at https://aqua.evoqua.com.
About Evoqua Water Technologies
Evoqua Water Technologies is a leading provider of mission-critical water and wastewater treatment solutions, offering a broad portfolio of products, services, and expertise to support industrial, municipal and recreational customers who value water. Evoqua has worked to protect water, the environment, and its employees for more than 100 years, earning a reputation for quality, safety, and reliability around the world. Headquartered in Pittsburgh, Pennsylvania, the company operates in more than 160 locations across ten countries. Serving more than 38,000 customers and 200,000 installations worldwide, our employees are united by a common purpose: Transforming Water. Enriching Life.®
What is the stockholder derivative action related to Evoqua Water Technologies (AQUA)?
Evoqua Water Technologies is addressing a stockholder derivative action that has resulted in a proposed settlement, involving enhanced corporate governance measures.
When is the hearing for the Evoqua Water Technologies settlement?
The hearing for final approval of the settlement is scheduled for November 2, 2021.
What governance measures are included in the Evoqua settlement?
The settlement includes replacing a non-independent director, enhancing the Director of Ethics and Compliance role, and establishing a Risk Committee.
Where can I find more details about the Evoqua settlement?
More details about the Evoqua settlement can be found on the company's Investor Relations website.